Temps partiel de thromboplastine : Questions médicales fréquentes
Nom anglais: Partial Thromboplastin Time
Descriptor UI:D010314
Tree Number:G09.188.660
Termes MeSH sélectionnés :
Interleukin-10
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Temps partiel de thromboplastine : Questions médicales les plus fréquentes",
"headline": "Temps partiel de thromboplastine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Temps partiel de thromboplastine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-19",
"dateModified": "2025-04-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Temps partiel de thromboplastine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phénomènes physiogiques du sang",
"url": "https://questionsmedicales.fr/mesh/D001790",
"about": {
"@type": "MedicalCondition",
"name": "Phénomènes physiogiques du sang",
"code": {
"@type": "MedicalCode",
"code": "D001790",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.188"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Temps partiel de thromboplastine",
"alternateName": "Partial Thromboplastin Time",
"code": {
"@type": "MedicalCode",
"code": "D010314",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Robert C Gosselin",
"url": "https://questionsmedicales.fr/author/Robert%20C%20Gosselin",
"affiliation": {
"@type": "Organization",
"name": "Davis Health System, Hemostasis and Thrombosis Center, University of California, Sacramento, California."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Dorothy M Adcock",
"url": "https://questionsmedicales.fr/author/Dorothy%20M%20Adcock",
"affiliation": {
"@type": "Organization",
"name": "Laboratory Corporation of America, Burlington, North Carolina."
}
},
{
"@type": "Person",
"name": "Gary W Moore",
"url": "https://questionsmedicales.fr/author/Gary%20W%20Moore",
"affiliation": {
"@type": "Organization",
"name": "Specialist Haemostasis Unit, Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."
}
},
{
"@type": "Person",
"name": "Wayne L Chandler",
"url": "https://questionsmedicales.fr/author/Wayne%20L%20Chandler",
"affiliation": {
"@type": "Organization",
"name": "Department of Laboratory Medicine, University of Washington, Seattle."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Epstein-Barr virus, interleukin-10 and multiple sclerosis: A ménage à trois.",
"datePublished": "2022-10-07",
"url": "https://questionsmedicales.fr/article/36275700",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.1028972"
}
},
{
"@type": "ScholarlyArticle",
"name": "Interleukin 10 (IL-10) gene variants and haplotypes in Tunisian women with polycystic ovary syndrome (PCOS): a case-control study.",
"datePublished": "2023-08-04",
"url": "https://questionsmedicales.fr/article/37541999",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11033-023-08706-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "HPV E6/E7mRNA association with interleukin 10 (rs1800872) polymorphism in a group of Macedonian women.",
"datePublished": "2022-05-31",
"url": "https://questionsmedicales.fr/article/35578823",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jmv.27858"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of serum levels of interleukins 1-beta, 10 and 12 in patients with acne vulgaris.",
"datePublished": "2022-09-25",
"url": "https://questionsmedicales.fr/article/36125396",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jocd.15399"
}
},
{
"@type": "ScholarlyArticle",
"name": "Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients.",
"datePublished": "2023-05-09",
"url": "https://questionsmedicales.fr/article/37160888",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/17534259231172079"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques respiratoires et circulatoires",
"item": "https://questionsmedicales.fr/mesh/D002943"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiogiques du sang",
"item": "https://questionsmedicales.fr/mesh/D001790"
},
{
"@type": "ListItem",
"position": 4,
"name": "Temps partiel de thromboplastine",
"item": "https://questionsmedicales.fr/mesh/D010314"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Temps partiel de thromboplastine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Temps partiel de thromboplastine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Temps partiel de thromboplastine",
"description": "Quel est l'objectif du test TPT ?\nQuand le TPT est-il prescrit ?\nComment se déroule le test TPT ?\nQuels résultats indiquent un TPT prolongé ?\nLe TPT est-il lié à d'autres tests ?",
"url": "https://questionsmedicales.fr/mesh/D010314?mesh_terms=Interleukin-10&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Temps partiel de thromboplastine",
"description": "Quels symptômes peuvent indiquer un problème de coagulation ?\nComment reconnaître une hémorragie interne ?\nLes symptômes varient-ils selon l'âge ?\nLes saignements de nez sont-ils un signe de problème de coagulation ?\nLes femmes enceintes doivent-elles surveiller leur TPT ?",
"url": "https://questionsmedicales.fr/mesh/D010314?mesh_terms=Interleukin-10&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Temps partiel de thromboplastine",
"description": "Comment prévenir les troubles de la coagulation ?\nLes vaccinations influencent-elles la coagulation ?\nLe suivi médical est-il essentiel ?\nLes exercices physiques aident-ils à la coagulation ?\nFaut-il éviter certains médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D010314?mesh_terms=Interleukin-10&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Temps partiel de thromboplastine",
"description": "Comment traiter un TPT prolongé ?\nLes anticoagulants affectent-ils le TPT ?\nDes suppléments peuvent-ils aider ?\nLe traitement est-il différent pour les enfants ?\nLes changements alimentaires influencent-ils le TPT ?",
"url": "https://questionsmedicales.fr/mesh/D010314?mesh_terms=Interleukin-10&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Temps partiel de thromboplastine",
"description": "Quelles sont les complications d'un TPT prolongé ?\nUn TPT anormal peut-il entraîner des AVC ?\nLes complications varient-elles selon l'âge ?\nComment gérer les complications liées au TPT ?\nLes complications peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D010314?mesh_terms=Interleukin-10&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Temps partiel de thromboplastine",
"description": "Quels sont les facteurs de risque de troubles de la coagulation ?\nLe tabagisme influence-t-il la coagulation ?\nL'obésité est-elle un facteur de risque ?\nLes maladies chroniques influencent-elles le TPT ?\nL'âge est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D010314?mesh_terms=Interleukin-10&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Quel est l'objectif du test TPT ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer la capacité de coagulation du sang et détecter des anomalies."
}
},
{
"@type": "Question",
"name": "Quand le TPT est-il prescrit ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Lors de l'évaluation des troubles de la coagulation ou avant une chirurgie."
}
},
{
"@type": "Question",
"name": "Comment se déroule le test TPT ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un échantillon de sang est prélevé et mélangé avec des réactifs pour mesurer le temps de coagulation."
}
},
{
"@type": "Question",
"name": "Quels résultats indiquent un TPT prolongé ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un TPT prolongé peut indiquer des troubles hémorragiques ou une carence en facteurs de coagulation."
}
},
{
"@type": "Question",
"name": "Le TPT est-il lié à d'autres tests ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est souvent associé à l'INR et au temps de prothrombine pour une évaluation complète."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème de coagulation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements excessifs, des ecchymoses fréquentes ou des saignements spontanés."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hémorragie interne ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des douleurs abdominales, des vomissements de sang ou des selles noires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées peuvent présenter des symptômes différents."
}
},
{
"@type": "Question",
"name": "Les saignements de nez sont-ils un signe de problème de coagulation ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des saignements de nez fréquents peuvent indiquer un trouble de la coagulation."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles surveiller leur TPT ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des modifications de la coagulation peuvent survenir pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles de la coagulation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain, éviter les blessures et suivre les conseils médicaux."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles la coagulation ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent affecter la coagulation, il est important de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il essentiel ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est crucial pour les personnes à risque de troubles de la coagulation."
}
},
{
"@type": "Question",
"name": "Les exercices physiques aident-ils à la coagulation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activité physique régulière peut améliorer la circulation sanguine et la coagulation."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains médicaments ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent interférer avec la coagulation, consultez un médecin."
}
},
{
"@type": "Question",
"name": "Comment traiter un TPT prolongé ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause sous-jacente, pouvant inclure des transfusions ou des médicaments."
}
},
{
"@type": "Question",
"name": "Les anticoagulants affectent-ils le TPT ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticoagulants comme l'héparine peuvent prolonger le TPT."
}
},
{
"@type": "Question",
"name": "Des suppléments peuvent-ils aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments de vitamine K peuvent être nécessaires en cas de carence."
}
},
{
"@type": "Question",
"name": "Le traitement est-il différent pour les enfants ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les dosages et les médicaments peuvent varier selon l'âge et le poids."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires influencent-ils le TPT ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en vitamine K peut améliorer la coagulation."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications d'un TPT prolongé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des saignements graves, des hématomes ou des thromboses."
}
},
{
"@type": "Question",
"name": "Un TPT anormal peut-il entraîner des AVC ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la coagulation peuvent augmenter le risque d'accidents vasculaires cérébraux."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon l'âge ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent être plus graves chez les personnes âgées ou les enfants."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées au TPT ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une gestion rapide et appropriée des saignements et des traitements médicaux est essentielle."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un suivi médical régulier et des traitements appropriés."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de troubles de la coagulation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, certaines maladies et l'utilisation de médicaments anticoagulants."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la coagulation ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut affecter la coagulation et augmenter le risque de thrombose."
}
},
{
"@type": "Question",
"name": "L'obésité est-elle un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité augmente le risque de troubles de la coagulation et de complications associées."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques influencent-elles le TPT ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou les maladies cardiaques peuvent affecter le TPT."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de troubles de la coagulation augmente avec l'âge."
}
}
]
}
]
}
Multiple Sclerosis (MS) is an autoimmune disease that is characterized by inflammation and demyelination of nerve cells. There is strong evidence that Epstein-Barr virus (EBV), a human herpesvirus inf...
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder that affects women in their child-bearing age, and is associated with insulin resistance and type 2 diabetes. The etiology of PCOS in...
115 cases and 120 controls were recruited in the current case control study. Rotterdam consensus criteria were used to diagnose PCOS patients. Genotyping for IL-10, rs1800896, rs1800871 and rs1800872 ...
Our study is the first to show how ethnicity influences the association of IL-10 gene variants with PCOS susceptibility. No allelic nor genetic association were observed between the tested variants an...
Interleukin 10 (IL-10) is an immunosuppressive cytokine and its genetic variants could have an indirect impact on viral biology and human papillomavirus (HPV) E6/E7 messenger RNA (mRNA) expression as ...
One of the most prevalent skin disorders is acne vulgaris. It is a distressing problem among young adults and adolescents. The pathophysiology of AV is significantly influenced by certain immune respo...
To measure the serum levels of IL-1 and IL-12, two pro-inflammatory cytokines, and IL-10, an anti-inflammatory cytokine, in AV patients and link those levels with the severity of the condition....
This study included 19 males and 23 females with AV(n = 42), with mean age of 21.79 ± 3.5. The control group included 19 males and 23 female (n = 42) with mean age of 22.05 ± 3.3 (p = 0.729). Serum le...
Our results indicate significant alterations in the monocyte-derived cytokine (MDCs) profile in patients with AV, IL-1 and IL-12 serum levels rose while IL-10 levels fell, reflecting an increase in pr...
Numerous immunosuppressive cells such as myeloid-derived suppressor cells (MDSCs) and inhibitory cytokines identified in melanoma microenvironment have the important role in immune escape. Therefore, ...
COVID-19 caused by the SARS-CoV-2 virus is widespread in all regions, and it disturbs host immune system functioning leading to extreme inflammatory reaction and hyperactivation of the immune response...
We assessed the levels of Interleukin-10 (IL-10), Interleukin-12 (IL-12), and Interleukin-18 (IL-18) in the gingival crevicular fluid (GCF) of subjects with advanced periodontitis (SIII-SIV) compared ...
This cross-sectional study involved subjects (n = 60) diagnosed with stage III grade B-C (n = 13) to stage IV grade C (n = 17) periodontitis, and periodontally healthy controls (n = 30). Clinical peri...
There were no significant differences in IL-12 level and IL-18/IL-10 ratio between the healthy and periodontitis groups (p = 0.413, p = 0.636, respectively). The IL-10 and IL-18 levels were significan...
There was a correlation between pocket depth and the presence of IL-18 and a strong association between periodontitis and a high level of IL-18. However, there were no direct correlations among the th...
Understanding the cytokine dynamics in GCF provides valuable insights into their potential clinical implications for periodontal disease diagnosis, risk assessment, and tailored therapeutic interventi...
The purpose of this study was to improve the immune compatibility and targeting abilities of IL10 nanoparticles coated with platelet membrane (IL10-PNPs) by glycosylation engineering in order to effec...
In this study, we removed sialic acids and added α (1,2)-fucose and α (1,3)-fucose to platelet membrane glycoprotein, thus engineering the glycosylation of IL10-PNPs (IL10-GE-PNPs). In vitro and in vi...
IL10-GE-PNPs were successfully constructed and demonstrated to effectively target and regulate macrophage polarization in both in vitro and in vivo settings. This regulation resulted in reduced prolif...
IL10-GE-PNPs emerged as a promising candidate for targeting vascular injury and exhibited potential as an innovative drug delivery system for suppressing vascular restenosis. The engineered glycosylat...
Balancing natural selection is a process by which genetic variants arise in populations that are beneficial to heterozygous carriers, but pathogenic when homozygous. We systematically investigated the...
Dopamine transmission from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) regulates important aspects of motivation and is influenced by the neuroimmune system. The neuroimmune system...